Profile
| Role | Director |
|---|---|
| Notability | 20/100 |
Board memberships
- PUMA BIOTECHNOLOGY, INC.
- Sintx Technologies, Inc.
- BioCardia, Inc.
Updated Jul 16, 2026
MOYES JAY M has filed 2 SEC Form 4 filings across 2 companies in the last 90 days — active on both sides. Lifetime open-market purchases: $14K. Lifetime open-market sales: $234K.
| Role | Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-16 | PBYI | PUMA BIOTECHNOLOGY, INC. | S — Open-market sale | 22.0K | $7.22 | $159K |
| 2026-06-16 | PBYI | PUMA BIOTECHNOLOGY, INC. | A — Grant or award | 27.0K | $0.00 | |
| 2026-02-25 | SINT | Sintx Technologies, Inc. | P — Open-market purchase | 1.0K | $2.91 | $3K |
| 2025-08-26 | SINT | Sintx Technologies, Inc. | P — Open-market purchase | 3.0K | $3.59 | $11K |
| 2025-06-13 | PBYI | PUMA BIOTECHNOLOGY, INC. | S — Open-market sale | 22.0K | $3.40 | $75K |
| 2025-06-11 | PBYI | PUMA BIOTECHNOLOGY, INC. | A — Grant or award | 27.0K | $0.00 |
MOYES JAY M is a corporate insider — currently tracked as Director of BioCardia, Inc. (BCDA). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 2 open-market purchases ($14K) and 2 open-market sales ($234K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live MOYES JAY M profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.